Contact Supplier

Contact Supplier

To get in touch with Bachem AG, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier


Bachem returns as sponsor to AsiaTIDES, Tokyo

news-releasesBachem AG
February 13th 2019

Bubendorf, Switzerland: –Peptide technology specialist Bachem AG will be a leading presence at this year’s AsiaTIDES oligonucleotide and peptide therapies symposium in Tokyo.

Once again, Bachem is a sponsor of the event, which will allow it to present its world-leading ‘Pioneering Partner for Peptides’ capabilities and product ranges , as well as its peptide synthesis technologies to Asian audiences.

High visibility

The Bachem stand (Booth 20) will be highly visible near the main entrance into the Exhibit Hall at Hilton Tokyo Bay Hotel and will showcase its extensive manufacturing capabilities of peptide-based APIs and research and production-focused custom synthesis services for research labs and pharma and biotech industries.

The stand will also feature latest developments, such as the ISO 13485 certificated production facilities and Bachem’s custom synthesis service catering for milligram up to kilogram scales.

Bachem are delighted to be returning to AsiaTIDES, which is a unique event in Asia for promoting oligonucleotide and peptide research and development.

Linear vs. convergent synthesis

Dr. Samson (Vice President API SPPS) will deliver a presentation on ‘Linear and Convergent Approaches to Peptide Synthesis – A Comparison from A Manufacturer’s Point of View’ during the afternoon of the final day of the conference. (1345hrs, February 28).

His talk will compare linear vs. convergent approaches for peptide synthesis, with pros and cons of each approach discussed from the point of view of production efficiencies.

About Bachem

The Bachem Group is the world’s only full service provider of peptides and provides a full range of other services to the pharma and biotech industries.

Under its banner Pioneering Partner for Peptides, Bachem specializes in the process development and manufacture of peptides and complex organic molecules as active pharmaceutical ingredients (APIs).

A comprehensive catalog of innovative biochemicals for research and exclusive custom syntheses for research labs complete its service portfolio.

Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the group has a global reach and shows total commitment to quality, innovation and partnership to its customers worldwide.

Bachem prioritizes continuous investment in R&D on chemistries and technologies as crucial for future success. Its ever-increasing knowledge of complex proteins and peptides derives from ongoing research in proteomics, as well as progress in mass spectrometry, synthesis and ligation technologies, complemented by collaboration with external research institutions.

Bachem has six production sites in the U.S. and in Europe along with research level production and full cGMP manufacturing facilities on both continents. These provide capacity to produce APIs, key intermediates, small molecule generics, new chemical entities (NCEs) and finished dosage forms at preclinical, clinical and production scales.

About AsiaTIDES 2019

The AsiaTIDES Oligonucleotide & Peptide Therapeutics conference is the only event in Asia bringing together science, technologies and partners to accelerate oligonucleotide and peptide molecules to market. Th event provides a forum for leading companies to share strategies and network.

The 3 day 2019 meeting will be held on 26th – 28th February and is expected to attract more than 250+ oligonucleotide and peptide leaders across Asia, Europe and North America and will feature keynote addresses by Dr. Jesper Lau, (Vice President for Protein and Peptide Chemistry at Novo Nordisk A/S), Dr. Thazha Prakash (Director of Medicinal Chemistry at Ionis Pharmaceuticals), Dr. ‘Mano’ Manoharan (Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals Inc.) and Dr. Chandra Vargeese (Head of Drug Discovery at WAVE Life Sciences).

The co-located exhibition will feature displays from more than 20+ global technology leaders, as well as peer-submitted posters that contain new and unpublished research from scientists working across all phases of oligonucleotide and peptide development.

The event is organized by KNECT 365 with further information at:

Contact Bachem AG

Simply fill out the form below to contact Bachem AG now.

Send Bachem AG a Message